Trial Profile
Duloxetine effects on brain fMRI [functional magnetic resonance imaging] response to emotionally valenced pictures in the treatment of patients with major depression.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 14 Nov 2011 Actual end date (April 2009) added as reported by ClinicalTrials.gov.
- 14 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 18 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.